English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 128 | Tables: 241 | More & Other
The global market for Sterile and Antiviral Packaging was estimated to be worth US$ 65 million in 2023 and is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030
The market for sterile and antiviral packaging is experiencing a significant upward trend in recent years. This trend is primarily driven by the growing demand for safe and hygienic packaging solutions in various industries, including healthcare, pharmaceuticals, food and beverage, and personal care.In the healthcare and pharmaceutical sectors, the need for sterile packaging is crucial to ensure the integrity and safety of medical devices, drugs, and other healthcare products. Sterile packaging helps prevent contamination and maintains the sterility of these products throughout their lifecycle. The increasing focus on infection control and patient safety has led to a higher demand for sterile packaging solutions.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sterile and Antiviral Packaging, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sterile and Antiviral Packaging by region & country, by Type, and by Application.
The Sterile and Antiviral Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile and Antiviral Packaging.
Market Segmentation
By Company
Avery Dennison Corporation
E.l.du Pont de Nemours
CCL Industries Inc
BioCote
Avient
Mondi
Biomaster
BASF
Lonza
Takex Labo Co.Ltd
Berry inc.
Segment by Type:
Hard Plastic
Flexible Material
Other
Segment by Application
Drug
Health Care
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sterile and Antiviral Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sterile and Antiviral Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sterile and Antiviral Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Sterile and Antiviral Packaging Product Introduction
1.2 Global Sterile and Antiviral Packaging Market Size Forecast
1.2.1 Global Sterile and Antiviral Packaging Sales Value (2019-2030)
1.2.2 Global Sterile and Antiviral Packaging Sales Volume (2019-2030)
1.2.3 Global Sterile and Antiviral Packaging Sales Price (2019-2030)
1.3 Sterile and Antiviral Packaging Market Trends & Drivers
1.3.1 Sterile and Antiviral Packaging Industry Trends
1.3.2 Sterile and Antiviral Packaging Market Drivers & Opportunity
1.3.3 Sterile and Antiviral Packaging Market Challenges
1.3.4 Sterile and Antiviral Packaging Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sterile and Antiviral Packaging Players Revenue Ranking (2023)
2.2 Global Sterile and Antiviral Packaging Revenue by Company (2019-2024)
2.3 Global Sterile and Antiviral Packaging Players Sales Volume Ranking (2023)
2.4 Global Sterile and Antiviral Packaging Sales Volume by Company Players (2019-2024)
2.5 Global Sterile and Antiviral Packaging Average Price by Company (2019-2024)
2.6 Key Manufacturers Sterile and Antiviral Packaging Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sterile and Antiviral Packaging Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sterile and Antiviral Packaging
2.9 Sterile and Antiviral Packaging Market Competitive Analysis
2.9.1 Sterile and Antiviral Packaging Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sterile and Antiviral Packaging Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile and Antiviral Packaging as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hard Plastic
3.1.2 Flexible Material
3.1.3 Other
3.2 Global Sterile and Antiviral Packaging Sales Value by Type
3.2.1 Global Sterile and Antiviral Packaging Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sterile and Antiviral Packaging Sales Value, by Type (2019-2030)
3.2.3 Global Sterile and Antiviral Packaging Sales Value, by Type (%) (2019-2030)
3.3 Global Sterile and Antiviral Packaging Sales Volume by Type
3.3.1 Global Sterile and Antiviral Packaging Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sterile and Antiviral Packaging Sales Volume, by Type (2019-2030)
3.3.3 Global Sterile and Antiviral Packaging Sales Volume, by Type (%) (2019-2030)
3.4 Global Sterile and Antiviral Packaging Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug
4.1.2 Health Care
4.1.3 Other
4.2 Global Sterile and Antiviral Packaging Sales Value by Application
4.2.1 Global Sterile and Antiviral Packaging Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sterile and Antiviral Packaging Sales Value, by Application (2019-2030)
4.2.3 Global Sterile and Antiviral Packaging Sales Value, by Application (%) (2019-2030)
4.3 Global Sterile and Antiviral Packaging Sales Volume by Application
4.3.1 Global Sterile and Antiviral Packaging Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sterile and Antiviral Packaging Sales Volume, by Application (2019-2030)
4.3.3 Global Sterile and Antiviral Packaging Sales Volume, by Application (%) (2019-2030)
4.4 Global Sterile and Antiviral Packaging Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sterile and Antiviral Packaging Sales Value by Region
5.1.1 Global Sterile and Antiviral Packaging Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sterile and Antiviral Packaging Sales Value by Region (2019-2024)
5.1.3 Global Sterile and Antiviral Packaging Sales Value by Region (2025-2030)
5.1.4 Global Sterile and Antiviral Packaging Sales Value by Region (%), (2019-2030)
5.2 Global Sterile and Antiviral Packaging Sales Volume by Region
5.2.1 Global Sterile and Antiviral Packaging Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sterile and Antiviral Packaging Sales Volume by Region (2019-2024)
5.2.3 Global Sterile and Antiviral Packaging Sales Volume by Region (2025-2030)
5.2.4 Global Sterile and Antiviral Packaging Sales Volume by Region (%), (2019-2030)
5.3 Global Sterile and Antiviral Packaging Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sterile and Antiviral Packaging Sales Value, 2019-2030
5.4.2 North America Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sterile and Antiviral Packaging Sales Value, 2019-2030
5.5.2 Europe Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sterile and Antiviral Packaging Sales Value, 2019-2030
5.6.2 Asia Pacific Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sterile and Antiviral Packaging Sales Value, 2019-2030
5.7.2 South America Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sterile and Antiviral Packaging Sales Value, 2019-2030
5.8.2 Middle East & Africa Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sterile and Antiviral Packaging Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sterile and Antiviral Packaging Sales Value
6.2.1 Key Countries/Regions Sterile and Antiviral Packaging Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sterile and Antiviral Packaging Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sterile and Antiviral Packaging Sales Value, 2019-2030
6.3.2 United States Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sterile and Antiviral Packaging Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sterile and Antiviral Packaging Sales Value, 2019-2030
6.4.2 Europe Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sterile and Antiviral Packaging Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sterile and Antiviral Packaging Sales Value, 2019-2030
6.5.2 China Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sterile and Antiviral Packaging Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sterile and Antiviral Packaging Sales Value, 2019-2030
6.6.2 Japan Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sterile and Antiviral Packaging Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sterile and Antiviral Packaging Sales Value, 2019-2030
6.7.2 South Korea Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sterile and Antiviral Packaging Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sterile and Antiviral Packaging Sales Value, 2019-2030
6.8.2 Southeast Asia Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sterile and Antiviral Packaging Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sterile and Antiviral Packaging Sales Value, 2019-2030
6.9.2 India Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sterile and Antiviral Packaging Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Avery Dennison Corporation
7.1.1 Avery Dennison Corporation Company Information
7.1.2 Avery Dennison Corporation Introduction and Business Overview
7.1.3 Avery Dennison Corporation Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Avery Dennison Corporation Sterile and Antiviral Packaging Product Offerings
7.1.5 Avery Dennison Corporation Recent Development
7.2 E.l.du Pont de Nemours
7.2.1 E.l.du Pont de Nemours Company Information
7.2.2 E.l.du Pont de Nemours Introduction and Business Overview
7.2.3 E.l.du Pont de Nemours Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.2.4 E.l.du Pont de Nemours Sterile and Antiviral Packaging Product Offerings
7.2.5 E.l.du Pont de Nemours Recent Development
7.3 CCL Industries Inc
7.3.1 CCL Industries Inc Company Information
7.3.2 CCL Industries Inc Introduction and Business Overview
7.3.3 CCL Industries Inc Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CCL Industries Inc Sterile and Antiviral Packaging Product Offerings
7.3.5 CCL Industries Inc Recent Development
7.4 BioCote
7.4.1 BioCote Company Information
7.4.2 BioCote Introduction and Business Overview
7.4.3 BioCote Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.4.4 BioCote Sterile and Antiviral Packaging Product Offerings
7.4.5 BioCote Recent Development
7.5 Avient
7.5.1 Avient Company Information
7.5.2 Avient Introduction and Business Overview
7.5.3 Avient Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Avient Sterile and Antiviral Packaging Product Offerings
7.5.5 Avient Recent Development
7.6 Mondi
7.6.1 Mondi Company Information
7.6.2 Mondi Introduction and Business Overview
7.6.3 Mondi Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mondi Sterile and Antiviral Packaging Product Offerings
7.6.5 Mondi Recent Development
7.7 Biomaster
7.7.1 Biomaster Company Information
7.7.2 Biomaster Introduction and Business Overview
7.7.3 Biomaster Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Biomaster Sterile and Antiviral Packaging Product Offerings
7.7.5 Biomaster Recent Development
7.8 BASF
7.8.1 BASF Company Information
7.8.2 BASF Introduction and Business Overview
7.8.3 BASF Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.8.4 BASF Sterile and Antiviral Packaging Product Offerings
7.8.5 BASF Recent Development
7.9 Lonza
7.9.1 Lonza Company Information
7.9.2 Lonza Introduction and Business Overview
7.9.3 Lonza Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Lonza Sterile and Antiviral Packaging Product Offerings
7.9.5 Lonza Recent Development
7.10 Takex Labo Co.Ltd
7.10.1 Takex Labo Co.Ltd Company Information
7.10.2 Takex Labo Co.Ltd Introduction and Business Overview
7.10.3 Takex Labo Co.Ltd Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Takex Labo Co.Ltd Sterile and Antiviral Packaging Product Offerings
7.10.5 Takex Labo Co.Ltd Recent Development
7.11 Berry inc.
7.11.1 Berry inc. Company Information
7.11.2 Berry inc. Introduction and Business Overview
7.11.3 Berry inc. Sterile and Antiviral Packaging Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Berry inc. Sterile and Antiviral Packaging Product Offerings
7.11.5 Berry inc. Recent Development
8 Industry Chain Analysis
8.1 Sterile and Antiviral Packaging Industrial Chain
8.2 Sterile and Antiviral Packaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sterile and Antiviral Packaging Sales Model
8.5.2 Sales Channel
8.5.3 Sterile and Antiviral Packaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Sterile and Antiviral Packaging Market Trends
Table 2. Sterile and Antiviral Packaging Market Drivers & Opportunity
Table 3. Sterile and Antiviral Packaging Market Challenges
Table 4. Sterile and Antiviral Packaging Market Restraints
Table 5. Global Sterile and Antiviral Packaging Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Sterile and Antiviral Packaging Revenue Market Share by Company (2019-2024)
Table 7. Global Sterile and Antiviral Packaging Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Sterile and Antiviral Packaging Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Sterile and Antiviral Packaging Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Sterile and Antiviral Packaging Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Sterile and Antiviral Packaging Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Sterile and Antiviral Packaging
Table 13. Global Sterile and Antiviral Packaging Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile and Antiviral Packaging as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Sterile and Antiviral Packaging Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Sterile and Antiviral Packaging Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Sterile and Antiviral Packaging Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Sterile and Antiviral Packaging Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Sterile and Antiviral Packaging Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Sterile and Antiviral Packaging Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Sterile and Antiviral Packaging Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Sterile and Antiviral Packaging Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Sterile and Antiviral Packaging Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Sterile and Antiviral Packaging Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Sterile and Antiviral Packaging Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Sterile and Antiviral Packaging Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Sterile and Antiviral Packaging Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Sterile and Antiviral Packaging Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Sterile and Antiviral Packaging Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Sterile and Antiviral Packaging Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Sterile and Antiviral Packaging Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Sterile and Antiviral Packaging Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Sterile and Antiviral Packaging Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Sterile and Antiviral Packaging Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Sterile and Antiviral Packaging Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Sterile and Antiviral Packaging Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Sterile and Antiviral Packaging Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Sterile and Antiviral Packaging Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Sterile and Antiviral Packaging Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Sterile and Antiviral Packaging Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Sterile and Antiviral Packaging Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Sterile and Antiviral Packaging Sales Value by Region (2019-2024) & (%)
Table 44. Global Sterile and Antiviral Packaging Sales Value by Region (2025-2030) & (%)
Table 45. Global Sterile and Antiviral Packaging Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Sterile and Antiviral Packaging Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Sterile and Antiviral Packaging Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Sterile and Antiviral Packaging Sales Volume by Region (2019-2024) & (%)
Table 49. Global Sterile and Antiviral Packaging Sales Volume by Region (2025-2030) & (%)
Table 50. Global Sterile and Antiviral Packaging Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Sterile and Antiviral Packaging Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Sterile and Antiviral Packaging Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Sterile and Antiviral Packaging Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Sterile and Antiviral Packaging Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Sterile and Antiviral Packaging Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Sterile and Antiviral Packaging Sales Volume, (2025-2030) & (K Units)
Table 57. Avery Dennison Corporation Company Information
Table 58. Avery Dennison Corporation Introduction and Business Overview
Table 59. Avery Dennison Corporation Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Avery Dennison Corporation Sterile and Antiviral Packaging Product Offerings
Table 61. Avery Dennison Corporation Recent Development
Table 62. E.l.du Pont de Nemours Company Information
Table 63. E.l.du Pont de Nemours Introduction and Business Overview
Table 64. E.l.du Pont de Nemours Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. E.l.du Pont de Nemours Sterile and Antiviral Packaging Product Offerings
Table 66. E.l.du Pont de Nemours Recent Development
Table 67. CCL Industries Inc Company Information
Table 68. CCL Industries Inc Introduction and Business Overview
Table 69. CCL Industries Inc Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. CCL Industries Inc Sterile and Antiviral Packaging Product Offerings
Table 71. CCL Industries Inc Recent Development
Table 72. BioCote Company Information
Table 73. BioCote Introduction and Business Overview
Table 74. BioCote Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. BioCote Sterile and Antiviral Packaging Product Offerings
Table 76. BioCote Recent Development
Table 77. Avient Company Information
Table 78. Avient Introduction and Business Overview
Table 79. Avient Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Avient Sterile and Antiviral Packaging Product Offerings
Table 81. Avient Recent Development
Table 82. Mondi Company Information
Table 83. Mondi Introduction and Business Overview
Table 84. Mondi Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Mondi Sterile and Antiviral Packaging Product Offerings
Table 86. Mondi Recent Development
Table 87. Biomaster Company Information
Table 88. Biomaster Introduction and Business Overview
Table 89. Biomaster Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Biomaster Sterile and Antiviral Packaging Product Offerings
Table 91. Biomaster Recent Development
Table 92. BASF Company Information
Table 93. BASF Introduction and Business Overview
Table 94. BASF Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. BASF Sterile and Antiviral Packaging Product Offerings
Table 96. BASF Recent Development
Table 97. Lonza Company Information
Table 98. Lonza Introduction and Business Overview
Table 99. Lonza Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Lonza Sterile and Antiviral Packaging Product Offerings
Table 101. Lonza Recent Development
Table 102. Takex Labo Co.Ltd Company Information
Table 103. Takex Labo Co.Ltd Introduction and Business Overview
Table 104. Takex Labo Co.Ltd Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Takex Labo Co.Ltd Sterile and Antiviral Packaging Product Offerings
Table 106. Takex Labo Co.Ltd Recent Development
Table 107. Berry inc. Company Information
Table 108. Berry inc. Introduction and Business Overview
Table 109. Berry inc. Sterile and Antiviral Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Berry inc. Sterile and Antiviral Packaging Product Offerings
Table 111. Berry inc. Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Sterile and Antiviral Packaging Downstream Customers
Table 115. Sterile and Antiviral Packaging Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Sterile and Antiviral Packaging Product Picture
Figure 2. Global Sterile and Antiviral Packaging Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Sterile and Antiviral Packaging Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Sterile and Antiviral Packaging Sales Volume (2019-2030) & (K Units)
Figure 5. Global Sterile and Antiviral Packaging Sales Price (2019-2030) & (US$/Unit)
Figure 6. Sterile and Antiviral Packaging Report Years Considered
Figure 7. Global Sterile and Antiviral Packaging Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Sterile and Antiviral Packaging Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sterile and Antiviral Packaging Revenue in 2023
Figure 10. Sterile and Antiviral Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Hard Plastic Picture
Figure 12. Flexible Material Picture
Figure 13. Other Picture
Figure 14. Global Sterile and Antiviral Packaging Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Sterile and Antiviral Packaging Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Sterile and Antiviral Packaging Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Sterile and Antiviral Packaging Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Sterile and Antiviral Packaging Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Drug
Figure 20. Product Picture of Health Care
Figure 21. Product Picture of Other
Figure 22. Global Sterile and Antiviral Packaging Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Sterile and Antiviral Packaging Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Sterile and Antiviral Packaging Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Sterile and Antiviral Packaging Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Sterile and Antiviral Packaging Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Sterile and Antiviral Packaging Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Sterile and Antiviral Packaging Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Sterile and Antiviral Packaging Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Sterile and Antiviral Packaging Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Sterile and Antiviral Packaging Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Sterile and Antiviral Packaging Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Sterile and Antiviral Packaging Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Sterile and Antiviral Packaging Sales Volume (%), (2019-2030)
Figure 39. United States Sterile and Antiviral Packaging Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Sterile and Antiviral Packaging Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Sterile and Antiviral Packaging Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Sterile and Antiviral Packaging Sales Value by Application (%), 2023 VS 2030
Figure 45. China Sterile and Antiviral Packaging Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
Figure 47. China Sterile and Antiviral Packaging Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Sterile and Antiviral Packaging Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Sterile and Antiviral Packaging Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Sterile and Antiviral Packaging Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Sterile and Antiviral Packaging Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Sterile and Antiviral Packaging Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Sterile and Antiviral Packaging Sales Value by Application (%), 2023 VS 2030
Figure 57. India Sterile and Antiviral Packaging Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Sterile and Antiviral Packaging Sales Value by Type (%), 2023 VS 2030
Figure 59. India Sterile and Antiviral Packaging Sales Value by Application (%), 2023 VS 2030
Figure 60. Sterile and Antiviral Packaging Industrial Chain
Figure 61. Sterile and Antiviral Packaging Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
